DiviDrip · GRI

GRI — GRI Bio, Inc.

GRI is GRI Bio, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.88. Market cap: $6M. Capital Quality Rank: 16/100 — Capital destroyer.

Stock snapshot

Price$2.88
Market cap$6M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)16 / 100 · Capital destroyer
Shareholder buyback yield-4.10%
Altman Z-score zoneDistress

About GRI

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

Listed2023Employees5HQLa Jolla, CASectorHealthcareWebsitegribio.com

Related non-dividend companies

Other non-dividend stocks investors research alongside GRI. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is GRI's current stock price?

GRI (GRI Bio, Inc.) is currently trading at $2.88.

Does GRI pay a dividend?

GRI (GRI Bio, Inc.) does not currently pay a regular dividend.

What is GRI's Capital Quality Rank?

GRI has a Capital Quality Rank of 16/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track GRI in DiviDrip

Add GRI to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow